The insider buying is too small to signal a material conviction call. The guidance cut and restructuring charges are the dominant narrative. Monitor for larger insider purchases or any 8-K filings on restructuring execution. The stock's reaction to the earnings/guidance news over the next 2-4 weeks will be more informative than these director purchases.
Price Chart
Executive Summary
Two Boston Scientific directors made open-market purchases totaling $277K in the week following the company's Q2 earnings report, which beat consensus but included a significant full-year guidance cut and a $700M-$800M restructuring plan. The insider buying is modest relative to the $69.2B market cap (0.0004%), but the timing—post-earnings and post-restructuring announcement—suggests directors see value at current levels despite the operational headwinds.
Key Financial Metrics
Key Facts
- Director Edward Ludwig purchased 5,000 shares at $45.48 for $227K on July 31.
- Director David Habiger purchased 1,042 shares at $48.07 for $50K on Aug 3.
- Total insider buying of $277K represents ~0.0004% of BSX's $69.2B market cap.
- Purchases occurred 2-5 days after Q2 earnings beat but guidance cut and restructuring announcement.
- EVP Fitzgerald Joseph's $3M discretionary transaction on July 31 is not an open-market buy/sell and is excluded from net direction.
Financial Impact
Insider purchases of $277K are trivial relative to $69.2B market cap (0.0004%).
Risk Factors
- Insider buying is de minimis relative to market cap and may be routine portfolio rebalancing.
- Guidance cut and $700M-$800M restructuring charges signal fundamental deceleration.
- Historical BSX insider cluster reports have a 40% win rate at T+20, suggesting limited predictive power.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-BSX-1786003781263 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 31, 2026 4w ago | Court Ruling | $48.30 $43.88 | ▼ −9.15% | ▼ −8.96% | $42.69 (−11.60%) |
Aug 26, 2026 5w ago | 8-K | $48.17 $43.72 | ▲ +9.24% | ▲ +10.44% | $42.69 (+11.37%) |
Aug 22, 2026 5w ago | Institutional Cluster | $49.01 $44.92 | ▼ −8.35% | ▼ −9.66% | $42.69 (−12.89%) |
Aug 7, 2026 8w ago | Insider Cluster | $49.31 $47.80 | ▼ −3.06% | ▼ −2.67% | $42.69 (−13.42%) |
Aug 7, 2026 8w ago | Insider Cluster | $49.31 $47.80 | ▼ −3.06% | ▼ −2.67% | $42.69 (−13.42%) |
Aug 5, 2026 8w ago | Insider Cluster | $47.74 $48.37 | ▲ +1.32% | ▲ +1.92% | $42.69 (−10.57%) |
Jul 29, 2026 9w ago | 8-K | $46.04 $48.17 | ▼ −4.63% | ▲ +0.39% | $42.69 (+7.27%) |
Jul 27, 2026 9w ago | 8-K | $46.06 $49.86 | ▲ +8.25% | ▲ +4.87% | $42.69 (−7.31%) |
Jul 27, 2026 9w ago | Court Ruling | $45.51 $49.01 | ▲ +7.69% | ▲ +4.39% | $42.69 (−6.19%) |
Jul 10, 2026 12w ago | Court Ruling | $44.77 $49.30 | ▲ +10.11% | ▲ +7.69% | $42.69 (−4.63%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access